Miller M - Search Results

1

Further insights into the pathophysiology of hyperapobetalipoproteinemia: role of basic proteins I, II, III.

Kwiterovich PO Jr, Motevalli M, Miller M, Bachorik PS, Kafonek SD, Chatterjee S, Beaty T, Virgil D. Kwiterovich PO Jr, et al. Among authors: miller m. Clin Chem. 1991 Mar;37(3):317-26. Clin Chem. 1991. PMID: 2004437 Review.

2

Platelet aggregation in hyperapobetalipoproteinemia.

Miller M, Bell W, Plano S, Connors J, Kennedy S, Kwiterovich P. Miller M, et al. Am J Hematol. 1991 Jul;37(3):209-11. doi: 10.1002/ajh.2830370317. Am J Hematol. 1991. PMID: 1858776

3

Acylation-stimulatory activity in hyperapobetalipoproteinemic fibroblasts: enhanced cholesterol esterification with another serum basic protein, BP II.

Kwiterovich P Jr, Motevalli M, Miller M. Kwiterovich P Jr, et al. Among authors: miller m. Proc Natl Acad Sci U S A. 1990 Nov;87(22):8980-4. doi: 10.1073/pnas.87.22.8980. Proc Natl Acad Sci U S A. 1990. PMID: 2247473 Free PMC article.

4

Apolipoprotein B-100 Hopkins (arginine4019----tryptophan). A new apolipoprotein B-100 variant in a family with premature atherosclerosis and hyperapobetalipoproteinemia.

Ladias JA, Kwiterovich PO Jr, Smith HH, Miller M, Bachorik PS, Forte T, Lusis AJ, Antonarakis SE. Ladias JA, et al. Among authors: miller m. JAMA. 1989 Oct 13;262(14):1980-8. doi: 10.1001/jama.262.14.1980. JAMA. 1989. PMID: 2778934

5

The effect of three serum basic proteins on the mass of lipids in normal and hyperapoB fibroblasts.

Kwiterovich PO Jr, Motevalli M, Miller M. Kwiterovich PO Jr, et al. Among authors: miller m. Arterioscler Thromb. 1994 Jan;14(1):1-7. doi: 10.1161/01.atv.14.1.1. Arterioscler Thromb. 1994. PMID: 8274464

6

Normal variation of plasma lipoproteins: postural effects on plasma concentrations of lipids, lipoproteins, and apolipoproteins.

Miller M, Bachorik PS, Cloey TA. Miller M, et al. Clin Chem. 1992 Apr;38(4):569-74. Clin Chem. 1992. PMID: 1533184

7

Long-term predictors of subsequent cardiovascular events with coronary artery disease and 'desirable' levels of plasma total cholesterol.

Miller M, Seidler A, Kwiterovich PO, Pearson TA. Miller M, et al. Circulation. 1992 Oct;86(4):1165-70. doi: 10.1161/01.cir.86.4.1165. Circulation. 1992. PMID: 1394924

8

Isolated low HDL-cholesterol as an important risk factor for coronary heart disease.

Miller M, Kwiterovich PO Jr. Miller M, et al. Eur Heart J. 1990 Dec;11 Suppl H:9-14. doi: 10.1093/eurheartj/11.suppl_h.9. Eur Heart J. 1990. PMID: 2073916 Review.

9

Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease.

Miller M, Mead LA, Kwiterovich PO Jr, Pearson TA. Miller M, et al. Am J Cardiol. 1990 Jan 1;65(1):1-5. doi: 10.1016/0002-9149(90)90017-u. Am J Cardiol. 1990. PMID: 2294675

10

Effect of gemfibrozil in men with primary isolated low high-density lipoprotein cholesterol: a randomized, double-blind, placebo-controlled, crossover study.

Miller M, Bachorik PS, McCrindle BW, Kwiterovich PO Jr. Miller M, et al. Am J Med. 1993 Jan;94(1):7-12. doi: 10.1016/0002-9343(93)90113-4. Am J Med. 1993. PMID: 8420303 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,287 results

Search Page

Filters